Suppr超能文献

用热休克蛋白gp96免疫后次要组织相容性抗原特异性细胞毒性T细胞的交叉启动

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

作者信息

Arnold D, Faath S, Rammensee H, Schild H

机构信息

Department of Tumorvirus-Immunology, German Cancer Research Center, Heidelberg.

出版信息

J Exp Med. 1995 Sep 1;182(3):885-9. doi: 10.1084/jem.182.3.885.

Abstract

Vaccination of mice with heat shock proteins isolated from tumor cells induces immunity to subsequent challenge with those tumor cells the heat shock protein was isolated from but not with other tumor cells (Udono, H., and P.K. Srivastava. 1994. J. Immunol. 152:5398-5403). The specificity of this immune response is caused by tumor-derived peptides bound to the heat shock proteins (Udono., H., and P.K. Srivastava. 1993. J. Exp. Med. 178:1391-1396). Our experiments show that a single immunization with the heat shock protein gp96 isolated from beta-galactosidase (beta-gal) expressing P815 cells (of DBA/2 origin) induces cytotoxic T lymphocytes (CTLs) specific for beta-gal, in addition to minor H antigens expressed by these cells. CTLs can be induced in mice that are major histocompatibility complex (MHC) identical to the gp96 donor cells (H-2d) as well as in mice with a different MHC (H-2b). Thus gp96 is able to induce "cross priming" (Matzinger, P., and M.J. Bevan. 1977. Cell. Immunol. 33:92-100), indicating that gp96-associated peptides are not limited to the MHC class I ligands of the gp96 donor cell. Our data confirm the notion that samples of all cellular antigens presentable by MHC class I molecules are represented by peptides associated with gp96 molecules of that cell, even if the fitting MHC molecule is not expressed. In addition, we extend previous reports on the in vivo immunogenicity of peptides associated gp96 molecules to two new groups of antigens, minor H antigens, and proteins expressed in the cytosol.

摘要

用从肿瘤细胞中分离出的热休克蛋白对小鼠进行免疫接种,可诱导小鼠对随后接种的、该热休克蛋白所源自的肿瘤细胞产生免疫,但对其他肿瘤细胞则无此作用(宇野博和斯里瓦斯塔瓦,1994年,《免疫学杂志》第152卷,第5398 - 5403页)。这种免疫反应的特异性是由与热休克蛋白结合的肿瘤衍生肽引起的(宇野博和斯里瓦斯塔瓦,1993年,《实验医学杂志》第178卷,第1391 - 1396页)。我们的实验表明,用从表达β - 半乳糖苷酶(β - gal)的P815细胞(源自DBA/2)中分离出的热休克蛋白gp96进行单次免疫接种,除了能诱导针对这些细胞表达的次要组织相容性抗原的细胞毒性T淋巴细胞(CTL)外,还能诱导针对β - gal的特异性CTL。在与gp96供体细胞主要组织相容性复合体(MHC)相同(H - 2d)的小鼠以及具有不同MHC(H - 2b)的小鼠中都能诱导出CTL。因此,gp96能够诱导“交叉启动”(马津格和贝万,1977年,《细胞免疫学》第33卷,第92 - 100页),这表明与gp96相关的肽不限于gp96供体细胞的MHC I类配体。我们的数据证实了这样一种观点,即MHC I类分子可呈递的所有细胞抗原样本都由与该细胞的gp96分子相关的肽所代表,即使相应的MHC分子未表达。此外,我们将先前关于与gp96分子相关的肽在体内免疫原性的报道扩展到了两组新的抗原,即次要组织相容性抗原和胞质中表达的蛋白质。

相似文献

8
On cross-priming of MHC class I-specific CTL: rule or exception?关于MHC I类特异性CTL的交叉启动:规则还是例外?
Eur J Immunol. 2002 Sep;32(9):2385-92. doi: 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V.

引用本文的文献

5
Pathways of Antigen Recognition by T Cells in Allograft Rejection.T 细胞在同种异体移植排斥中对抗原的识别途径。
Transplantation. 2023 Apr 1;107(4):827-837. doi: 10.1097/TP.0000000000004420. Epub 2022 Nov 10.
6
Immunosurveillance of cancer and the heat shock protein-CD91 pathway.肿瘤的免疫监视和热休克蛋白-CD91 途径。
Cell Immunol. 2019 Sep;343:103814. doi: 10.1016/j.cellimm.2018.05.007. Epub 2018 May 16.

本文引用的文献

1
Peptides naturally presented by MHC class I molecules.由MHC I类分子天然呈递的肽段。
Annu Rev Immunol. 1993;11:213-44. doi: 10.1146/annurev.iy.11.040193.001241.
4
Heat shock protein vaccines against cancer.抗癌症的热休克蛋白疫苗。
J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):352-6. doi: 10.1097/00002371-199311000-00016.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验